[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371364-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371364-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-the-roles-of-ncrnas-in-prostate-cancer-via-the-pi3kaktmtor-signaling-pathway","Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway","","Although androgen deprivation therapy and chemotherapy are widely used for prostate cancer, clinical outcomes remain limited, particularly for advanced chemotherapy-resistant disease. The PI3K/AKT/mTOR (PAM) pathway is frequently aberrantly activated and drives tumorigenesis, metastasis, resistance to castration therapy, chemoresistance, and recurrence. Noncoding RNAs (ncRNAs)—including lncRNAs, miRNAs, circRNAs, and piRNAs—can regulate PAM signaling at transcriptional and posttranscriptional levels, influencing growth, metastasis, angiogenesis, and tumor stemness. Summarizing PAM-associated ncRNA types and their functions and clinical roles supports ncRNA-targeted diagnostic and therapeutic strategies for prostate cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-the-roles-of-ncrnas-in-prostate-cancer-via-the-pi3kaktmtor-signaling-pathway/371364/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-the-roles-of-ncrnas-in-prostate-cancer-via-the-pi3kaktmtor-signaling-pathway/371364.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are current prostate cancer treatments still insufficient for advanced cases?","Question",{"text":63,"@type":64},"Androgen deprivation therapy and chemotherapy have not achieved desired clinical results, especially in advanced chemotherapy-resistant prostate cancer, where drug resistance can develop after a period of treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What makes the PI3K/AKT/mTOR (PAM) pathway important in prostate cancer?",{"text":68,"@type":64},"The PAM pathway is highly conserved and is often abnormally activated in malignant tumors. It regulates tumor proliferation, apoptosis, metastasis, and angiogenesis, and is linked to resistance, recurrence, and progression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which types of ncRNAs are discussed as regulators of the PAM pathway?",{"text":72,"@type":64},"The document highlights long noncoding RNAs (lncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), and Piwi-interacting RNAs (piRNAs) as ncRNAs that can participate in the PAM pathway and affect prostate cancer phenotypes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371364,1790369789,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","TYPE Review  \nPUBLISHED 18 March 2025  \nDOI 10.3389/fimmu.2025.1525741  \nOPEN ACCESS  \nEDITED BY  \nAlice Conigliaro,  \nUniversity of Palermo, Italy  \nREVIEWED BY  \nNadeem Bhat,  \nUniversity of Miami, United States Mohd Shuaib,  \nCentral University of Punjab, India  \n*CORRESPONDENCE  \nWeihua Yin  \n[ywh1939@163.com](ywh1939@163.com)  \nRECEIVED 10 November 2024  \nACCEPTED 27 February 2025  \nPUBLISHED 18 March 2025  \nCITATION  \nGuo R, Shi L, Chen Y, Lin C and Yin W (2025)  \nExploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway.  \nFront. Immunol. 16:1525741 .  \ndoi: 10.3389/fimmu.2025.1525741  \nCOPYRIGHT  \n© 2025 Guo, Shi, Chen, Lin and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExploring the roles of ncRNAs in prostate cancer via the PI3K/ AKT/mTOR signaling pathway  \nRongwang Guo 1, Liji Shi 2, Yonghui Chen 2, Canling Lin 2 and Weihua Yin 3*  \n1 Nanchang University, 999 University Avenue, Honggutan District, Nanchang, China, 2School of Chemical and Biological Engineering, Yichun College, Yichun, China, 3 Department of Oncology, Baoan Central Hospital of Shenzhen, Bao’ an District, Shenzhen, China  \nAlthough various treatment options are available for prostate cancer (PCa), including androgen deprivation therapy (ADT) and chemotherapy, these approaches have not achieved the desired results clinically, especially in the treatment of advanced chemotherapy-resistant PCa. The PI3K/AKT/mTOR (PAM) signaling pathway is a classical pathway that is aberrantly activated in cancer cells and promotes the tumorigenesis, metastasis, resistance to castration therapy, chemoresistance, and recurrence of PCa. Noncoding RNAs (ncRNAs) are a class of RNAs that do not encode proteins. However, some ncRNAs have recently been shown to be differentially expressed in tumor tissues compared with noncancerous tissues and play important roles at the transcription and posttranscription levels. Among the types of ncRNAs, long noncoding RNAs (lncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), and Piwi-interacting RNAs (piRNAs) can participate in the PAM pathway to regulate PCa growth, metastasis, angiogenesis, and tumor stemness. Therefore, ncRNA therapy that targets the PAM signaling pathway is expected to be a novel and effective approach for treating PCa. In this paper, we summarize the types of ncRNAs that are associated with the PAM pathway in PCa cells as well as the functions and clinical roles of these ncRNAs in PCa. We hope to provide novel and effective strategies for the clinical diagnosis and treatment of PCa.  \nKEYWORDS  \nprostate cancer, ncRNA, PI3K/AKT/mTOR, metastasis, tumor growth  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nGuo et al. 10.3389/fimmu.2025.1525741  \nGRAPHICAL ABSTRACT  \n1 Introduction  \nAccording to Global Cancer Statistics 2022, prostate cancer (PCa) is the fourth most common malignant tumor worldwide (incidence of 7.3%), and it is the second most prevalent malignant tumor in men (prevalence of 14.2%) and the ﬁfth leading cause of malignant tumor-related death in men (7.3% of tumor-related deaths) (1) . Moreover, PCa has a heterogeneous regional distribution, and it is the most common cancer in 118 countries (e.g., around northern Europe, Australia-New Zealand, and the Caribbean) (1) . Advanced PCa is the main cause of PCa-related death, and it is treated mainly with androgen deprivation therapy (ADT) and chemotherapy; however, advanced PCa is susceptible to drug resistance development after a period of treatment (2) . Therefore, understanding the mechanisms under","cbCaiiMCJ2NdkLTC","https://ap.wps.com/l/cbCaiiMCJ2NdkLTC","pdf",6944346,"English","# 1 Introduction\n## Prostate cancer burden and treatment limitations\n## Rationale for the PI3K/AKT/mTOR (PAM) pathway\n## Immune response and PAM pathway inhibition\n## Overview of noncoding RNAs and their roles in prostate cancer","[{\"question\":\"Why are current prostate cancer treatments still insufficient for advanced cases?\",\"answer\":\"Androgen deprivation therapy and chemotherapy have not achieved desired clinical results, especially in advanced chemotherapy-resistant prostate cancer, where drug resistance can develop after a period of treatment.\"},{\"question\":\"What makes the PI3K/AKT/mTOR (PAM) pathway important in prostate cancer?\",\"answer\":\"The PAM pathway is highly conserved and is often abnormally activated in malignant tumors. It regulates tumor proliferation, apoptosis, metastasis, and angiogenesis, and is linked to resistance, recurrence, and progression.\"},{\"question\":\"Which types of ncRNAs are discussed as regulators of the PAM pathway?\",\"answer\":\"The document highlights long noncoding RNAs (lncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), and Piwi-interacting RNAs (piRNAs) as ncRNAs that can participate in the PAM pathway and affect prostate cancer phenotypes.\"}]","Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway | PDF",1790191903,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93dae0a630f96c02af860faebdd28f44.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2f1280736e291b6d34da49994aa9a61.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d072578108b31e01427eae3cb982453f.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31875ddfc719a76e9680c7759790ffee.webp",980,1385]